Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:25 am Purchase |
2024-12-31 | 13G | Revolution Medicines, Inc. RVMD |
JANUS HENDERSON GROUP PLC JHG |
9,483,999 5.200% |
9,483,999 (New Position) |
Filing History |
| 2024-11-08 10:52 am Sale |
2024-09-30 | 13G | Revolution Medicines, Inc. RVMD |
WELLINGTON MANAGEMENT CO LLP | 11,401,394 6.830% |
-3,480,692 (-23.39%) |
Filing History |
| 2024-02-14 6:30 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 132,579 0.100% |
-7,066,121 (-98.16%) |
Filing History |
| 2024-02-14 09:26 am Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 5,981,212 3.600% |
-1,574,376 (-20.84%) |
Filing History |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 14,634,391 8.930% |
7,072,481 (+93.53%) |
Filing History |
| 2024-02-13 06:06 am Purchase |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BB BIOTECH AG | 5,046,700 3.100% |
269,138 (+5.63%) |
Filing History |
| 2024-02-12 5:11 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
FARALLON CAPITAL PARTNERS LP | 6,750,204 4.100% |
-12,276 (-0.18%) |
Filing History |
| 2024-02-09 5:22 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 46 0.000% |
-3,347,153 (-100.00%) |
Filing History |
| 2024-02-08 10:17 am Purchase |
2023-12-29 | 13G | Revolution Medicines, Inc. RVMD |
WELLINGTON MANAGEMENT CO LLP | 14,882,086 9.090% |
662,656 (+4.66%) |
Filing History |
| 2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BLACKROCK INC BLK |
12,954,314 7.900% |
6,378,368 (+97.00%) |
Filing History |
| 2023-11-09 5:18 pm Purchase |
2023-10-31 | 13G | Revolution Medicines, Inc. RVMD |
FARALLON CAPITAL PARTNERS LP | 6,762,480 6.200% |
6,762,480 (New Position) |
Filing History |
| 2023-11-09 1:26 pm Purchase |
2023-10-31 | 13G | Revolution Medicines, Inc. RVMD |
WELLINGTON MANAGEMENT CO LLP | 14,219,430 12.990% |
5,345,456 (+60.24%) |
Filing History |
| 2023-06-30 4:33 pm Purchase |
2023-06-22 | 13G | Revolution Medicines, Inc. RVMD |
BIOTECHNOLOGY VALUE FUND L P | 7,555,588 7.100% |
5,745,039 (+317.31%) |
Filing History |
| 2023-06-16 4:12 pm Purchase |
2023-06-07 | 13G | Revolution Medicines, Inc. RVMD |
EcoR1 Capital LLC | 7,198,700 6.800% |
2,720,650 (+60.76%) |
Filing History |
| 2023-02-14 4:15 pm Purchase |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BB BIOTECH AG | 4,777,562 5.400% |
175,000 (+3.80%) |
Filing History |
| 2023-02-14 4:03 pm Sale |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
Third Rock Ventures III L.P. | 1,939,692 2.200% |
-3,713,598 (-65.69%) |
Filing History |
| 2023-02-13 4:23 pm Unchanged |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,347,199 3.800% |
0 (Unchanged) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Revolution Medicines, Inc. RVMD |
The Vanguard Group | 7,561,910 8.520% |
1,262,301 (+20.04%) |
Filing History |
| 2023-02-06 2:56 pm Sale |
2022-12-30 | 13G | Revolution Medicines, Inc. RVMD |
WELLINGTON MANAGEMENT CO LLP | 8,873,974 9.990% |
-62,495 (-0.70%) |
Filing History |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
BLACKROCK INC BLK |
6,575,946 7.400% |
1,100,727 (+20.10%) |
Filing History |